Gestational diabetes

Women with a history of gestational diabetes have a significantly increased risk for long-term mortality regardless of whether or not they subsequently developed type 2 diabetes.

Identifying and treating women with gestational diabetes before 20 weeks’ gestation improves their pregnancy outcomes, shows the randomized TOBOGM trial.

Impaired glucose tolerance during pregnancy that does not meet the criteria for gestational diabetes nevertheless increases the likelihood that women will later develop type 2 diabetes, a study shows.

Researchers find that controlling modifiable risk factors limits the risk for developing type 2 diabetes in women with previous gestational diabetes, even if they have overweight or high genetic risk.

Using the lower IADPSG glycemic criteria rather than the HAPO criteria diagnoses more women with gestational diabetes but does not result in fewer babies being born large for gestational age, shows a randomized trial.

A systematic review and meta-analysis, which adjusted for confounding factors, has shown that gestational diabetes is associated with a range of adverse pregnancy outcomes that vary according to insulin use.

Researchers report that the frequency of some adverse gestational diabetes outcomes has risen over recent years in the USA, with women from ethnic minority groups most likely to be affected.

Being in a minority ethnic group and having low socioeconomic status increase women’s risk for developing certain long-term health complications after a pregnancy affected by gestational diabetes, a study shows.